Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

1211 - Unraveling a poor-prognosis CLL subgroup: from IGHV bias and AID activation to altered T-cell profiles

    Primary Author / Presenter(s)

  • Santiago Rodríguez, MSc

    PhD Student
    Research Laboratory on Chronic Lymphocytic Leukemia, Institut Pasteur, Uruguay
    Montevideo, Montevideo, Uruguay

    • Co-Author(s)

  • Eugenia Payque, MSc

    Research Laboratory on Chronic Lymphocytic Leukemia, Institut Pasteur, Uruguay
    Montevideo, Montevideo, Uruguay

  • RU

    Rita Uría, MD

    Assistant Investigator
    Research Laboratory on Chronic Lymphocytic Leukemia, Institut Pasteur, Uruguay
    Montevideo, Montevideo, Uruguay

  • JS

    Jorge Souto

    Research Laboratory on Chronic Lymphocytic Leukemia, Institut Pasteur de Montevideo
    Montevideo, Uruguay

    • Co-Author(s)

  • D

    Diego Álvarez, MSc

    Centro Asistencial de Docencia e Investigación, CADI, Universidad de Magallanes, Magallanes y de la Antartica Chilena, Chile

    • Co-Author(s)

  • AL

    Ana Ines Landoni, MD

    Hospital Maciel, ASSE
    Montevideo, Montevideo, Uruguay

  • VR

    Victoria Remedi, MD

    Hospital Maciel
    Montevideo, Uruguay

  • CO

    Carolina Oliver, MD

    Hematologist
    Hematology Department, CASMU
    Montevideo, Montevideo, Uruguay

  • SR

    Sabrina Ranero, MD

    Hospital de Clínicas
    Montevideo, Uruguay

  • VI

    Victoria Irigoin, MD

    Hematologist
    Hospital Británico. CASMU
    Montevideo, Montevideo, Uruguay

  • VL

    Virginia Lema, MD

    Hematologist
    Hematology Department, Hospital Central de las Fuerzas Armadas (FFAA)
    Montevideo, Montevideo, Uruguay

  • MH

    Marcelo Hill, MD, PhD

    Principal Investigator
    Immunobiology Department, School of Medicine, University of the Republic, Montevideo, Uruguay

  • MF

    María Florencia Festari, PhD

    Immunobiology Department, School of Medicine, University of the Republic, Montevideo, Uruguay
    Montevideo, Montevideo, Uruguay

    • Co-Author(s)

  • Marcelo A. Navarrete, MD, PhD

    Universidad de Magallanes
    Punta Arena, Magallanes y de la Antartica Chilena, Chile

    • Co-Author(s)

  • Pablo J. Oppezzo, Sr., PhD

    Principal Investigator
    Research Laboratory on Chronic Lymphocytic Leukemia, Institut Pasteur, Uruguay
    Montevideo, Montevideo, Uruguay